EXPAREL® Partnerships

Back

Pacira owns all product rights to EXPAREL® for use in all markets. As such, we believe the global opportunity for EXPAREL use in the management of postsurgical pain presents a large addressable market opportunity. Based upon this opportunity, we are pursuing commercial partnerships in regions outside of the United States.

The management of postsurgical pain in animal health settings also represents a potentially large market for EXPAREL; we may also consider potential partnerships for developing and commercializing these applications in the future.